Krystal Biotech, Inc. KRYS Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s common stock, shares authorized (in shares)?
- Krystal Biotech, Inc. (KRYS) reported common stock, shares authorized (in shares) of $80M in Q1 2026.
- How has Krystal Biotech, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- Krystal Biotech, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $80M to $80M.
- What is the long-term trend for Krystal Biotech, Inc.'s common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $80M to $80M.